General Information
Revision date
2014-06-19
Product name
Sodium formaldehyde sulfoxylate dihydrate 95%
CAS No.
6035-47-8
supplier name
PRO Chemical & Dye
Icons in SDS
Company Information
company name
PRO Chemical & Dye
GHS Information
Signal word
Warning
Hazard Codes
Hazard statements (CLP)
H302, H312, H315, H319, H332, H335, H341
Hazard statements
Code
Statements
H302
Harmful if swallowed
Section 2
SECTION 2: Hazards identification
IDENTlFlCATION NFPA Rating Emergency Telephone Numbers: 800-255-3924 ChemTel. (United States) + 1 01 813-248-0585 (Outside the United States)
Hazard statements
Irritant, Mutagen H302 Harmful if swallowed. H312 Harmful in contact with skin. H315 Causes skin irritation. H319 Causes serious eye irritation. H332 Harmful if inhaled. H335 May cause respiratory irritation. H341 Suspected of causing genetic defects.
Acute Health Hazards
Irritant to eyes, skin, mucous membranes and respiratory system. May be harmful by ingestion, inhalation or skin absorption.
Health hazards
Not Available
HMIS® ratings
H 1 F O P O
NFPA Ratings
H 1 F O R O To the best of our knowledge, the toxicological properties of this chemical have not been thoroughly investigated. Use appropriate procedures and precautions to prevent or minimize exposure.
Signal word
Warning
Precautionary statements
P261 Avoid breathing dust / fume/ gas/ mist/ vapors/ spray. P280 Wear protective gloves/protective clothing/eye protection/face protection. P301+P312 IF SWALLOWED: Call a POISON CENTER or doctor/physician if you feel unwell. P302+P3S2 IF ON SKIN: Wash with plenty of soap and water. P304+P340 IF INHALED: Remove victim to fresh air and keep at rest in a position comfortable for breathing. P30S+P351+P338 IF IN EYES: Rinse cautiously with water for several minutes. Remove contact lenses, if present and easy to do. Continue rinsing. P332+P313 If skin irritation occurs: Get medical advice/ attention. P406 Store in a corrosive resistant container with a resistant inner liner. EUH031 Contact with acid liberates toxic gas. Supplemental Statements):